The use of extracorporeal membrane oxygenation (ECMO) in treating cardiogenic shock related to infarction is being reevaluated. Recent studies and analyses have raised questions about its effectiveness, with some findings suggesting it may not improve outcomes or may even be associated with additional complications. The role of ECMO in managing cardiogenic shock remains uncertain, with various trials and research yielding mixed results.